United States Patent ( 10 ) Patent No . : US 7479 , 375 B 2
(54) METHOD FOR CLASSIFYINGA 5,372,946 A 12/1994 Cusak et al. MCROORGANISM IN A BIOLOGICAL 5,389,547 A 2f1995 Tanaka et al. SAMPLE 5,401,647 A 3, 1995 Tanaka et al. 5,474,984 A 12/1995 Tanaka et al. (75) Inventors: Norman R. Wainwright, Falmouth, MA 5,504,011 A 4, 1996 Gavin et al. 5,518,006 A 5/1996 Mawhirt et al. (US); Dana M. Nutter, Charleston, SC 5.534.226 A 7/1996 Gavin etal (US) 5,550,030 A 8/1996 Tanaka et al. 5,574,023 A 11/1996 Shibata et al. (73) Assignee: Charles River Laboratories, Inc., 5,591.403 A 1/1997 Gavin et al. Wilmington, MA (US) 5,591,628 A 1/1997 Baek et al. 5,605,806 A 2/1997 Tanaka et al. (*) Notice: Subject to any disclaimer, the term of this 5,637,474 A 6/1997 Takaoka et al. patent is extended or adjusted under 35 D380,555 S 7/1997 Kurosaki et al. U.S.C. 154(b) by 264 days. 5,681,710 A 10/1997 Tanaka et al. 5,695,948 A 12/1997 Tanaka et al. (21) Appl. No.: 11/331,600 5,702,882 A 12/1997 Tamura et al. D390,661 S 2/1998 Foggia (22) Filed: Jan. 13, 2006 (Continued)
In the spiny lobster (Panulirus interruptus) the prophenoloxidase is located in plasma not in haemocytes.
In the spiny lobster (Panulirus interruptus), unlike other crustaceans most of the prophenoloxidase (proPO) was detected in cell-free plasma (86.3%). In spite of its location, lobster proPO activating system has a similar activation mechanism to other crustacean proPO systems. Haemocyte lysate was able to activate the plasma proPO indicating location of the prophenoloxidase activating enzyme (PPAE) in haemocytes. Lobster haemocyte PPAE was isolated by affinity chromatography and its participation as activating enzyme was demonstrated. This enzyme is a serine-proteinase that transforms the inactive form (proPO) to an active one (phenoloxidase). The PPAE was also present in the cell-free supernatant of haemocytes previously incubated with Vibrio alginolyticus.
Effect of Calcium Glycerophosphate on Demineralization in an in vitro Biofilm Model
The aim was to investigate the anti-caries properties of calcium glycerophosphate (CaGP) using an in vitro bacterial flow cell model. Four flow cells, inoculated from a chemostat containing a seven-organism bacterial consortium, were pulsed with sucrose twice daily, to provide an acidic challenge and pH-cycling conditions. Blocks of enamel and dentine were mounted in each flow cell. In a study on the effect of CaGP concentration, CaGP was pulsed into three of the flow cells, at the same time as the sucrose, to give concentrations of 0.10, 0.25 and 0.50%. Water was pulsed into the fourth flow cell with the sucrose. Microradiography revealed a significant dose response of decreasing demineralization as CaGP concentration increased. Reductions at 0.25 and 0.5% were significant when compared to the control. A second study investigated the effect of timing of CaGP pulsing, relative to sucrose, on enamel and dentine demineralization. CaGP (flow cell concentration 0.2%), was pulsed 1 h before, during or 1 h after the sucrose pulse; a water control was employed. In enamel, pulsing CaGP before the sucrose reduced demineralization significantly compared to concurrent pulsing, which in turn gave a significant reduction compared to pulsing after sucrose, which did not reduce demineralization significantly compared to the water control. In dentine, CaGP reduced demineralization significantly only when pulsed before the sucrose. The findings suggest that in vivo, the anti-caries potential of CaGP may be greater if it is applied before a cariogenic challenge.